Dr. Bruce D. Kohrman, MD

Dr. Kohrman practices at Neuroscience Consultants in South Miami, Florida.

Dr. Kohrman's NPI, 1053321604, was assigned on August 8, 2006. Dr. Kohrman graduated from Cleveland Medical College, Homeopathic in 1982. Dr. Kohrman holds Florida license ME53396.

Dr. Kohrman's primary practice is Neuroscience Consultants, at 7000 Sw 62nd Ave, South Miami, FL 33143 in Miami-Dade County. The practice phone is (786) 924-1311.

Dr. Kohrman's primary practice is Neuroscience Consultants in South Miami, Florida. Dr. Kohrman is also affiliated with Baptist Health Baptist Hospital. The medical group on file is First Choice Neurology. Dmand AI also links Dr. Kohrman to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kohrman practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kohrman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kohrman is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Kohrman's licenses on file in 2 states: Florida and Utah.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, hereditary polyneuropathy and lower back pain among the conditions Dr. Kohrman treats.

CMS data shows 736 Medicare services from Dr. Kohrman across 17 procedure codes in 2024, for 263 Medicare patients. Medicare paid $86,602 for them. Every service was in an office.

CMS counts 263 Medicare patients who saw Dr. Kohrman in 2024. The largest group is 75 to 84, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kohrman's median patient age at 66, with 63% women.

In 2024, Dr. Kohrman wrote 900 Medicare Part D claims for 181 patients. 96% of them were for generic drugs. CMS names the drug for 741 of them, across 18 drugs with 11 or more claims each, at $111,979 in total drug cost. In 2023, CMS named 719 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kohrman for performance year 2024, reported individually. Dr. Kohrman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kohrman as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Kohrman in 2014. 2014 was the busiest year, with 2. Dr. Kohrman's most frequent co-authors are Robert J. Bargar, MD, Peter James Goadsby, MD and David Bruce Kudrow, MD.

Dmand AI links Dr. Kohrman to 2 clinical trials. Conditions studied include Alzheimer Disease, Migraine without Aura and Migraine with Aura.

CMS Open Payments shows 878 general payments to Dr. Kohrman from 67 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Abbvie Inc. paid the most, $2,211. It also lists 11 research payments totaling $3,831 from 2016 to 2017.

Dmand AI lists 1 award for Dr. Kohrman.

Dr. Kohrman graduated from Cleveland Medical College, Homeopathic in 1982. Dr. Kohrman is a member of AAN.

Dr. Kohrman is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.